Newswise

The National Institute of Allergy and Infectious Diseases co-hosted a workshop on mucosal vaccines for COVID-19, with researchers emphasizing the need for improvement. No COVID-19 mucosal vaccines have been authorized for use in the US or Europe, but at least 44 are in preclinical development. The workshop concluded that research into mucosal vaccine development is a priority, and could lead to improved vaccines for other diseases.

by
The National Institute of Allergy and Infectious Diseases co-hosted a workshop on mucosal vaccines for COVID-19, with researchers emphasizing the need for improvement. No COVID-19 mucosal vaccines have been authorized for use in the US or Europe, but at least 44 are in preclinical development. The workshop concluded that research into mucosal vaccine development is a priority, and could lead to improved vaccines for other diseases.

The COVID-19 pandemic has had a profound impact on the world, affecting every aspect of life, from work to travel, education to healthcare. While several vaccines have been developed and authorized for emergency use, the race to produce a more effective and convenient vaccine continues. One promising approach is the mucosal COVID-19 vaccine. Unlike traditional … Read more

A new study warns that treating hypoxic COVID-19 patients with higher dose corticosteroids leads to increased risk of death.

by
A new study warns that treating hypoxic COVID-19 patients with higher dose corticosteroids leads to increased risk of death.

The COVID-19 pandemic has put the world on edge and has led to a scramble by doctors and researchers to find an effective treatment for the virus. In the search for possible treatments, corticosteroids have emerged as a common option for reducing inflammation in patients with severe COVID-19 symptoms. However, new research highlights the risks … Read more

New research identifies pathways to reducing multi-organ injury caused by COVID-19 cytokine storms and the possibility of specific dual-pathway treatments.

by
New research identifies pathways to reducing multi-organ injury caused by COVID-19 cytokine storms and the possibility of specific dual-pathway treatments.

The COVID-19 pandemic has brought the world to a standstill, and as scientists and medical professionals continue to race against time to find a cure or vaccine, we are learning more about the virus with every passing day. One of the most devastating consequences of the viral infection is the development of cytokine storms, which … Read more

Scientists at Washington University School of Medicine have developed a vaccine against norovirus by piggybacking on vaccines for rotavirus. The researchers added a protein from a strain of norovirus to a harmless strain of rotavirus. Mice that received the experimental vaccine produced neutralising antibodies against both viruses, leading to hopes that the breakthrough could allow for the distribution of a bivalent vaccine to protect against both stomach bugs. The next step will be to find out whether the vaccine works in preventing sickness and death due to norovirus.

by
Scientists at Washington University School of Medicine have developed a vaccine against norovirus by piggybacking on vaccines for rotavirus. The researchers added a protein from a strain of norovirus to a harmless strain of rotavirus. Mice that received the experimental vaccine produced neutralising antibodies against both viruses, leading to hopes that the breakthrough could allow for the distribution of a bivalent vaccine to protect against both stomach bugs. The next step will be to find out whether the vaccine works in preventing sickness and death due to norovirus.

Norovirus, also known as the “winter vomiting bug,” is the leading cause of foodborne illness in the world, affecting millions of people annually. With its highly contagious nature, norovirus can easily spread through contaminated food and water, as well as person-to-person contact. In recent years, outbreaks of norovirus have increasingly become a public health concern, … Read more